Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
Ampol Profit Surges as Refining Margins Hit Record Highs 
SK Hynix Shares Fall as Workers Reject Wage Deal 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Add as a preferred source on Google
BUENA, N.J., May 01, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.
Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8th at 12:50 p.m. ET.
The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
